Founder Mutation in RSPH4A Identified in Patients of Hispanic Descent with Primary Ciliary Dyskinesia

ABSTRACT Primary ciliary dyskinesia (PCD) is a rare, autosomal recessive, genetically heterogeneous disorder characterized by ciliary dysfunction resulting in chronic oto‐sino‐pulmonary disease, respiratory distress in term neonates, laterality (situs) defects, and bronchiectasis. Diagnosis has trad...

Full description

Saved in:
Bibliographic Details
Published inHuman mutation Vol. 34; no. 10; pp. 1352 - 1356
Main Authors Daniels, M. Leigh Anne, Leigh, Margaret W., Davis, Stephanie D., Armstrong, Michael C., Carson, Johnny L., Hazucha, Milan, Dell, Sharon D., Eriksson, Maria, Collins, Francis S., Knowles, Michael R., Zariwala, Maimoona A.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.10.2013
Hindawi Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ABSTRACT Primary ciliary dyskinesia (PCD) is a rare, autosomal recessive, genetically heterogeneous disorder characterized by ciliary dysfunction resulting in chronic oto‐sino‐pulmonary disease, respiratory distress in term neonates, laterality (situs) defects, and bronchiectasis. Diagnosis has traditionally relied on ciliary ultrastructural abnormalities seen by electron microscopy. Mutations in radial spoke head proteins occur in PCD patients with central apparatus defects. Advances in genetic testing have been crucial in addressing the diagnostic challenge. Here, we describe a novel splice‐site mutation (c.921+3_6delAAGT) in RSPH4A, which leads to a premature translation termination signal in nine subjects with PCD (seven families). Loss‐of‐function was confirmed with quantitative ciliary ultrastructural analysis, measurement of ciliary beat frequency and waveform, and transcript analysis. All nine individuals carrying c.921+3_6delAAGT splice‐site mutation in RSPH4A were Hispanic with ancestry tracing to Puerto Rico. This mutation is a founder mutation and a common cause of PCD without situs abnormalities in patients of Puerto Rican descent. Primary ciliary dyskinesia (PCD) is a rare, autosomal recessive, genetically heterogeneous disorder characterized by ciliary dysfunction resulting in chronic otosino‐pulmonary disease, respiratory distress in term neonates, laterality (situs) defects, and bronchiectasis. Here, we describe a novel splice‐site mutation (c.921+3_6delAAGT) in RSPH4A, which leads to a premature translation termination signal in nine Hispanic subjects with Puerto Rican ancestry with PCD. This mutation is a founder mutation and a common cause of PCD without situs abnormalities in patients of Puerto Rican descent.
Bibliography:National Heart, Lung, and Blood Institute (NHLBI) - No. 5 U54 HL096458-06
NCATS
National Human Genome Research Institute (NHGRI)
National Center for Advancing Translational Sciences (NCATS) - No. UL1 TR000083, CFF R026-CR07
istex:39B5A17F5C849444499E9EBF89BEB9569CEEBD06
NHGRI
US National Institutes of Health (NIH)-National Heart, Lung, and Blood Institute (NHLBI) - No. 5R01HL071798
Office of Rare Diseases Research (ORDR)
T32 Research Training Program "Multidisciplinary Research Training in Pulmonary Diseases" - No. T32 HL007106
ORDR
NHLBI
ark:/67375/WNG-M4KR4711-1
ArticleID:HUMU22371
US National Institute of Health (NIH) Office of the Director
Contract grant sponsors: US National Institute of Health (NIH) Office of the Director; Office of Rare Diseases Research (ORDR); National Heart, Lung, and Blood Institute (NHLBI); (5 U54 HL096458‐06); US National Institutes of Health (NIH)—National Heart, Lung, and Blood Institute (NHLBI) (5R01HL071798); T32 Research Training Program “Multidisciplinary Research Training in Pulmonary Diseases” (T32 HL007106); National Human Genome Research Institute (NHGRI); National Center for Advancing Translational Sciences (NCATS) (UL1 TR000083, CFF R026‐CR07); ORDR; NHLBI; NHGRI; NCATS. The Genetic Disorders of Mucociliary Clearance (U54HL096458) is a part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN), supported through collaboration between the NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS), and the National Heart Lung and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Communicated by Garry R. Cutting
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current address: Section of Pediatric Pulmonology, Allergy and Sleep Medicine, James Whitcomb Ruket Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
ISSN:1059-7794
1098-1004
1098-1004
DOI:10.1002/humu.22371